SynopsisThe global market for Cardiac Ablation was valued at US$ 7295 million in the year 2024 and is projected to reach a revised size of US$ 13910 million by 2031, growing at a CAGR of 9.8% during the forecast period. This report mainly studies cardiac ablatio.....
SynopsisThe global market for Soliris (Eculizumab) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Eculizumab, sold under the trade name Soliris, is a m.....
SynopsisThe global market for Dental X-ray Tube was valued at US$ 232 million in the year 2024 and is projected to reach a revised size of US$ 373 million by 2031, growing at a CAGR of 7.1% during the forecast period. An X-ray tube is an energy converter. It rec.....
SynopsisThe global market for Eslicarbazepine Acetate Tablets was valued at US$ 218 million in the year 2024 and is projected to reach a revised size of US$ 311 million by 2031, growing at a CAGR of 5.1% during the forecast period. Eslicarbazepine acetate is ind.....
SynopsisThe global market for Antimicrobial Peptides was valued at US$ 5.5 million in the year 2024 and is projected to reach a revised size of US$ 8 million by 2031, growing at a CAGR of 5.4% during the forecast period. Antimicrobial peptides (AMPs), also calle.....
SynopsisThe global market for Cough Lozenges was valued at US$ 1800 million in the year 2024 and is projected to reach a revised size of US$ 2232 million by 2031, growing at a CAGR of 3.1% during the forecast period. Cough lozenges are a type of medication speci.....
SynopsisThe global market for Protein Crystallization and Crystallography was valued at US$ 2052 million in the year 2024 and is projected to reach a revised size of US$ 3294 million by 2031, growing at a CAGR of 7.1% during the forecast period. The Global Prote.....
SynopsisThe global market for Clindamycin Palmitate Hydrochloride Granules was valued at US$ 285 million in the year 2024 and is projected to reach a revised size of US$ 378 million by 2031, growing at a CAGR of 4.1% during the forecast period. Clindamycin palmi.....
SynopsisThe global market for Benign Prostatic Hyperplasia Stent was valued at US$ 1300 million in the year 2024 and is projected to reach a revised size of US$ 1951 million by 2031, growing at a CAGR of 6.0% during the forecast period. Benign prostatic hyperpla.....
SynopsisThe global market for Mercaptopurine Tablets was valued at US$ 43.1 million in the year 2024 and is projected to reach a revised size of US$ 59 million by 2031, growing at a CAGR of 4.5% during the forecast period. Mercaptopurine is used alone or with ot.....
